BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20443236)

  • 21. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
    Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
    J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
    Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
    Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of parameters affecting engraftment in children undergoing allogeneic BM transplants.
    Kletzel M; Haut PR; Olzewski M; Figuerres E
    Cytotherapy; 1999; 1(5):417-22. PubMed ID: 20443234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
    Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA
    Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases.
    Gaipa G; Dassi M; Perseghin P; Venturi N; Corti P; Bonanomi S; Balduzzi A; Longoni D; Uderzo C; Biondi A; Masera G; Parini R; Bertagnolio B; Uziel G; Peters C; Rovelli A
    Bone Marrow Transplant; 2003 May; 31(10):857-60. PubMed ID: 12748661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations.
    Schumm M; Handgretinger R; Pfeiffer M; Feuchtinger T; Kuci S; Faul C; Vogel W; Bethge W; Lang P
    Cytotherapy; 2006; 8(5):465-72. PubMed ID: 17050251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries.
    Takahashi TA; Rebulla P; Armitage S; van Beckhoven J; Eichler H; Kekomäki R; Letowska M; Wahab F; Moroff G
    Cytotherapy; 2006; 8(3):254-64. PubMed ID: 16793734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax.
    Aktas M; Radke TF; Strauer BE; Wernet P; Kogler G
    Cytotherapy; 2008; 10(2):203-11. PubMed ID: 18368599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow processing for transplantation using the COBE spectra cell separator.
    Korístek Z; Mayer J
    J Hematother Stem Cell Res; 1999 Aug; 8(4):443-8. PubMed ID: 10634182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells.
    Cornetta K; Gharpure V; Mills B; Hromas R; Abonour R; Broun ER; Traycoff CM; Hanna M; Wyman N; Danielson C; Gonin R; Kunkel LK; Oldham F; Srour EF
    Bone Marrow Transplant; 1998 Jan; 21(1):65-71. PubMed ID: 9486497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
    Roberts MM; Dyson P; Rawling C; Thorp D; Rawling T; White D; Horvath N; Bardy P; Hui CH; Dart GW; To LB; Hughes TP
    Cytotherapy; 2003; 5(6):534-41. PubMed ID: 14660049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy.
    Elias M; van Zanten J; Hospers GA; Setroikromo A; de Jong MA; de Leij LF; Mulder NH
    J Clin Apher; 2005 Dec; 20(4):197-207. PubMed ID: 15892082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts.
    Behringer D; Bertz H; Schmoor C; Berger C; Dwenger A; Finke J
    Bone Marrow Transplant; 1999 Aug; 24(3):295-302. PubMed ID: 10455369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
    Rowley S; Davis J; Braine H; Jones R; Yeager A; Saral R; Santos G
    Prog Clin Biol Res; 1990; 333():369-77. PubMed ID: 2308991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantation.
    Wiesneth M; Schreiner T; Friedrich W; Müller S; Maccari B; Erne E; Bischof C; Kubanek B
    Transfus Sci; 1996 Dec; 17(4):629-35. PubMed ID: 10168563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient isolation of human CD34 positive hemopoietic progenitor cells by immune panninga.
    Holyoake TL; Alcorn MJ; Richmond LJ; Freshney MG; Pearson C; Fitzsimons E; Steward WP; Dunlop DJ; Pragnell IB
    Stem Cells; 1994 Jan; 12(1):114-24. PubMed ID: 7511456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of nucleated red blood cells in allogeneic marrow graft and impact of processing on recovery.
    Marolleau JP; Vanneaux V; Rea D; Ternaux B; Delasse V; Hubert V; Chantre E; Traineau R; Robin M; Benbunan M; Socié G; Larghero J
    Transfusion; 2007 Feb; 47(2):266-71. PubMed ID: 17302773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
    Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
    Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.